GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative
Volume 1 / Year 2012 / Issue 3-4
Editorial
Reference price systems: stakeholder dialogue and involvement
Author(s): Sabine Vogler, PhD
Page: 114-5Abstract: Dylst et al. provide a detailed overview about the characteristics of reference price systems in Europe and discuss their possible impact. The role of stakeholders in the implementation of this policy measure requires further attention. Submitted: 16 September 2012; Revised: 17 September 2012; Accepted: 19 September 2012; Published online first: 21 September 2012 Dylst […]
Generics policies–a globally-relevant implementation challenge
Author(s): Andy Gray, MScPharm, FPS, FFIP
Page: 113-4Abstract: Vogler and Zimmerman, reporting on the 2011 Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference, have noted the incomplete application of generics policies in many settings, and have called for more consistent policies. While many of the basic building blocks of such policies are well described, some elements required renewed attention. Submitted: 23 July 2012; […]
